BioSmart Co (038460) Fair Value & Analysis
Technology · KR · Market cap 70.9B KRW
Fair value as of: Aug 13, 2026
From 14 valuation models · updated yesterday
Fair value updated Aug 13, 2026, revised from 7,129 KRW to 9,981 KRW (+40.0%) since Jul 22, 2026. Share price +3.6% over the past month.
Below-average quality, screening 247% undervalued on our models.
What matters now
- The large discount to fair value meets weak quality (42/100). That raises the risk this is a value trap rather than a bargain.
- The price is below even our cautious bear case (7,485 KRW). The market is more pessimistic than our downside scenario.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range 2,325 KRW – 9,290 KRW · fair‑value band 7,485 KRW – 12,476 KRW · the 2,880 KRW price screens below the 9,981 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
BioSmart Co (038460) currently trades at 2,880 KRW, while our model-based Fair Value estimate is 9,981 KRW, implying the stock looks roughly 246.6% undervalued today. The Quality Score stands at 42/100 (below-average quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, BioSmart Co generated revenue of 333B KRW at a net margin of 0.7%. Revenue grew 94.2% year over year. Net debt stands at 41.8B KRW. Fundamentals as of Aug 13, 2026
Our scenario range runs from 7,485 KRW (bear case) to 12,476 KRW (bull case); at 2,880 KRW, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 58% below its 52-week high and 11% above its 52-week low, currently below its 200-day average. For context, the median of 10 Technology peers we cover trades at 11% fair-value upside, at 247%, 038460 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 14 models by family
Widest divergence: Growth Earnings (11,461 KRW) versus Asset-Based (3,817 KRW). Highest evidence: Residual Income (76).
Notify me when 038460 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 45 · Market factors (momentum, volatility) 18
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
BioSmart Co.,Ltd. manufactures and sells magnetic stripe (MS) cards in South Korea. The company's magnetic stripe cards include credit cards, smart cards, traffic cards, securities cards, etc.
Full company description
BioSmart Co.,Ltd. manufactures and sells magnetic stripe (MS) cards in South Korea. The company's magnetic stripe cards include credit cards, smart cards, traffic cards, securities cards, etc. It also sells card equipment, such as traffic card issuing machinery, smart card issuing machinery, credit card issuing machinery, etc.; provides card issuing services comprising MS card and IC chip personalization, and photo-transferring; and develops software programs related to credit card issuing. The company was formerly known as KBC Corporation and changed its name to BioSmart Co.,Ltd. in March 2007. BioSmart Co.,Ltd. was founded in 1971 and is headquartered in Seoul, South Korea.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
BioSmart Co reported revenue of 483B KRW in FY2025 versus 189B KRW in FY2021, a compound +26.4%/yr. Reported net income was 9.0B KRW in FY2025, compounding +59.5%/yr from FY2021.
Watch 038460: get an alert when its fair value changes →
Peer Group
Electronic Equipment & Parts · 19 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Electronic Equipment & Parts stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| STCube, Inc 052020 | 9,130 KRW | 2,160 KRW | -76% |
| VINATech Co 126340 | 76,700 KRW | 24,754 KRW | -68% |
| Partron Co 091700 | 5,860 KRW | 13,133 KRW | +124% |
| Amotech Co 052710 | 13,520 KRW | 14,277 KRW | +6% |
| KHVATEC Co 060720 | 11,770 KRW | 23,424 KRW | +99% |
| MNTech Co 095500 | 7,440 KRW | 8,280 KRW | +11% |
| Namuga Co 190510 | 14,070 KRW | 44,255 KRW | +215% |
| Powerlogics. Co 047310 | 3,200 KRW | 5,000 KRW | +56% |
| e-LITECOM CO., Ltd 041520 | 11,570 KRW | 11,520 KRW | -0% |
| Ajinextek Co 059120 | 7,440 KRW | 3,455 KRW | -54% |
Compare BioSmart Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Technology stocks →
Frequently asked questions
Is BioSmart Co (038460) overvalued or undervalued?
What is the fair value of 038460?
What is the quality score of 038460?
What is the revenue of BioSmart Co (038460)?
What is the net profit margin of 038460?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track BioSmart Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.